VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors GBX 16.41 +0.27 (+1.69%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors CYBG vs. CCFS, CIHL, IL0A, JEO, OCI, AGT.LN, AFX, JESC, SLPE, and BGSCShould you be buying VanEck Bionic Engineering UCITS ETF A Acc stock or one of its competitors? The main competitors of VanEck Bionic Engineering UCITS ETF A Acc include Charter Court Financial Services Grp (CCFS), Caribbean Investment (CIHL), Permanent TSB Group (IL0A), European Opportunities Trust (JEO), Oakley Capital Investments (OCI), AVI Global Trust (AGT.LN), Alpha FX Group (AFX), JPMorgan European Smaller Companies Trust (JESC), Standard Life Private Equity Trust (SLPE), and BMO Global Smaller Companies (BGSC). VanEck Bionic Engineering UCITS ETF A Acc vs. Charter Court Financial Services Grp Caribbean Investment Permanent TSB Group European Opportunities Trust Oakley Capital Investments AVI Global Trust Alpha FX Group JPMorgan European Smaller Companies Trust Standard Life Private Equity Trust BMO Global Smaller Companies VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Charter Court Financial Services Grp (LON:CCFS) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations, community ranking and risk. Is CYBG or CCFS a better dividend stock? VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Charter Court Financial Services Grp pays an annual dividend of GBX 0.09 per share. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Charter Court Financial Services Grp pays out 0.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio. Does the media favor CYBG or CCFS? In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Charter Court Financial Services Grp'saverage media sentiment score. Company Overall Sentiment VanEck Bionic Engineering UCITS ETF A Acc Neutral Charter Court Financial Services Grp Neutral Does the MarketBeat Community favor CYBG or CCFS? VanEck Bionic Engineering UCITS ETF A Acc received 104 more outperform votes than Charter Court Financial Services Grp when rated by MarketBeat users. However, 73.88% of users gave Charter Court Financial Services Grp an outperform vote while only 50.88% of users gave VanEck Bionic Engineering UCITS ETF A Acc an outperform vote. CompanyUnderperformOutperformVanEck Bionic Engineering UCITS ETF A AccOutperform Votes20350.88% Underperform Votes19649.12% Charter Court Financial Services GrpOutperform Votes9973.88% Underperform Votes3526.12% Is CYBG or CCFS more profitable? Company Net Margins Return on Equity Return on Assets VanEck Bionic Engineering UCITS ETF A AccN/A N/A N/A Charter Court Financial Services Grp N/A N/A N/A Which has higher earnings and valuation, CYBG or CCFS? VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Charter Court Financial Services Grp, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVanEck Bionic Engineering UCITS ETF A Acc£1.24B0.19N/A-£7.10-2.31Charter Court Financial Services Grp£221.10M0.00N/A£46.30N/A SummaryVanEck Bionic Engineering UCITS ETF A Acc beats Charter Court Financial Services Grp on 4 of the 7 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office... I put all the details together for you here — but please hurry. Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBG and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYBG vs. The Competition Export to ExcelMetricVanEck Bionic Engineering UCITS ETF A AccBanks IndustryFinance SectorLON ExchangeMarket Cap£235.37M£235.37M£11.30B£1.90BDividend Yield2.25%2.25%5.65%5.55%P/E Ratio-2.31N/A26.721,821.81Price / Sales0.1919.0134.97386,342.76Price / Cash0.130.1318.7328.54Price / Book0.050.052.612.78Net IncomeN/AN/A£1.04B£157.16M7 Day Performance-0.60%-0.12%-2.91%-2.00%1 Month Performance-2.13%-0.43%-3.48%21.23%1 Year Performance1.22%0.24%10.96%29.20% VanEck Bionic Engineering UCITS ETF A Acc Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYBGVanEck Bionic Engineering UCITS ETF A AccN/AGBX 16.41+1.7%N/A+2.0%£235.37M£1.24B-2.315,762CCFSCharter Court Financial Services GrpN/AGBX 295+3.7%N/AN/A£713.62M£221.10M6.37676Gap UpCIHLCaribbean InvestmentN/AGBX 26.50flatN/AN/A£35.27M£29.20M3.08N/AGap UpHigh Trading VolumeIL0APermanent TSB GroupN/AGBX 2.38flatN/AN/A£12.99M£406M5.532,236JEOEuropean Opportunities TrustN/AGBX 843-2.4%N/AN/A£886.70M£-62,326,000.00-12.93N/AOCIOakley Capital InvestmentsN/AGBX 502flatN/A+1.2%£885.63M£99.09M1,004.00N/AInsider TradeNews CoveragePositive NewsAGT.LNAVI Global TrustN/AN/AN/AN/A£812.93M£51.62M20.82N/AHigh Trading VolumeAFXAlpha FX GroupN/AGBX 1,920-0.5%N/AN/A£810.18M£89.43M3,200.00214JESCJPMorgan European Smaller Companies TrustN/AGBX 499-1.0%N/AN/A£795.72M£114.05M7.60N/APositive NewsSLPEStandard Life Private Equity TrustN/AGBX 512-1.5%N/A+18.3%£787.18M£251.60M3.30N/ABGSCBMO Global Smaller CompaniesN/AGBX 140.60-0.8%N/AN/A£769.56M£303.85M2.77N/A Related Companies and Tools Related Companies Charter Court Financial Services Grp Competitors Caribbean Investment Competitors Permanent TSB Group Competitors European Opportunities Trust Competitors Oakley Capital Investments Competitors AVI Global Trust Competitors Alpha FX Group Competitors JPMorgan European Smaller Companies Trust Competitors Standard Life Private Equity Trust Competitors BMO Global Smaller Companies Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:CYBG) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Bionic Engineering UCITS ETF A Acc Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Bionic Engineering UCITS ETF A Acc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.